Zdrowie i gospodarka · 06/08/2014
FDA Releases Draft Guidance for Industry on Upper Facial Lines: Developing Botulinum Toxin Drug Products
The Food and Drug Administration (FDA) has released a draft guidance document to help pharmaceutical companies design clinical trials for botulinum toxin-based treatments targeting upper facial lines, addressing safety concerns.
Source: Federal Register — Food and Drug AdministrationOpen original release →